Jae Woong Jang, Aaron Abrams, Anugayathri Jawahar, Hatice Savas, Ximing J Yang, Vikas Mehta, Marina Schnauss, Edward M Schaeffer, Ridwan Alam, Ashley E Ross
{"title":"Detection of MRI-Invisible Disease Using PSMA PET/CT in a Patient Considering Focal Therapy.","authors":"Jae Woong Jang, Aaron Abrams, Anugayathri Jawahar, Hatice Savas, Ximing J Yang, Vikas Mehta, Marina Schnauss, Edward M Schaeffer, Ridwan Alam, Ashley E Ross","doi":"10.1155/criu/2981515","DOIUrl":null,"url":null,"abstract":"<p><p>Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion-harboring cancer detected only on PSMA PET/CT. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT05852041.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2025 ","pages":"2981515"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964713/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/criu/2981515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion-harboring cancer detected only on PSMA PET/CT. Trial Registration: ClinicalTrials.gov identifier: NCT05852041.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
